Human leukocyte antigen gene polymorphisms are associated with systemic inflammation in hepatitis B virus-related hepatocellular carcinoma

References

• ChenWZhengRBaadePDCancer statistics in China, 2015CA Cancer J Clin201666211513226808342
   PubMed Web of Science ®Google Scholar
• DiakosCICharlesKAMcMillanDCClarkeSJCancer-related inflammation and treatment effectivenessLancet Oncol20141511e493e50325281468
   PubMed Web of Science ®Google Scholar
• GrivennikovSIGretenFRKarinMImmunity, inflammation, and cancerCell20111406883899
   Web of Science ®Google Scholar
• HanahanDWeinbergRAHallmarks of cancer: the next generationCell2011144564667421376230
   PubMed Web of Science ®Google Scholar
• AinoHSumieSNiizekiTThe systemic inflammatory response as a prognostic factor for advanced hepatocellular carcinoma with extrahepatic metastasisMol Clin Oncol201651838827330772
   PubMedGoogle Scholar
• ChanSLChanAWHChanAKCSystematic evaluation of circulating inflammatory markers for hepatocellular carcinomaLiver Int201737228028927501075
   PubMed Web of Science ®Google Scholar
• HowellJPinatoDJRamaswamiRIntegration of the cancer-related inflammatory response as a stratifying biomarker of survival in hepatocellular carcinoma treated with sorafenibOncotarget2017822361613617028212535
   PubMedGoogle Scholar
• PinatoDJStebbingJIshizukaMA novel and validated prognostic index in hepatocellular carcinoma: the inflammation based index (IBI)J Hepatol20125751013102022732513
   PubMed Web of Science ®Google Scholar
• McDonaldBSpicerJGiannaisBFallavollitaLBrodtPFerriLESystemic inflammation increases cancer cell adhesion to hepatic sinusoids by neutrophil mediated mechanismsInt J Cancer200912561298130519431213
   PubMed Web of Science ®Google Scholar
• TajiriKBabaHKawaiKNeutrophil-to-lymphocyte ratio predicts recurrence after radiofrequency ablation in hepatitis B virus infectionJ Gastroenterol Hepatol20163171291129926729319
   PubMed Web of Science ®Google Scholar
• PinatoDJSharmaRAn inflammation-based prognostic index predicts survival advantage after transarterial chemoembolization in hepatocellular carcinomaTransl Res2012160214615222677364
   PubMed Web of Science ®Google Scholar
• XuLYuSZhuangLSystemic inflammation response index (SIRI) predicts prognosis in hepatocellular carcinoma patientsOnco-target20178213495434960
   Google Scholar
• QiXLiJDengHLiHSuCGuoXNeutrophil-to-lymphocyte ratio for the prognostic assessment of hepatocellular carcinoma: a systematic review and meta-analysis of observational studiesOncotarget2016729452834530127304193
   PubMed Web of Science ®Google Scholar
• XueTCJiaQAGeNLChenYZhangBHYeSLImbalance in systemic inflammation and immune response following transarterial chemoembolization potentially increases metastatic risk in huge hepatocellular carcinomaTumour Biol201536118797880326058874
   PubMedGoogle Scholar
• MbarekHOchiHUrabeYA genome-wide association study of chronic hepatitis B identified novel risk locus in a Japanese populationHum Mol Genet201120193884389221750111
   PubMed Web of Science ®Google Scholar
• HuZLiuYZhaiXNew loci associated with chronic hepatitis B virus infection in Han ChineseNat Genet201345121499150324162738
   PubMed Web of Science ®Google Scholar
• KimYJKimHYLeeJ-HA genome-wide association study identified new variants associated with the risk of chronic hepatitis BHum Mol Genet201322204233423823760081
   PubMed Web of Science ®Google Scholar
• NishidaNSawaiHMatsuuraKGenome-wide association study confirming association of HLA-DP with protection against chronic hepatitis B and viral clearance in Japanese and KoreanPLoS One20127618
   Web of Science ®Google Scholar
• LiSQianJYangYGWAS identifies novel susceptibility loci on 6p21.32 and 21q21.3 for hepatocellular carcinoma in chronic hepatitis B virus carriersPLoS Genet201287e100279122807686
   PubMed Web of Science ®Google Scholar
• CliffordRJZhangJMeerzamanDMGenetic variations at loci involved in the immune response are risk factors for hepatocellular carcinomaHepatology20105262034204321105107
   PubMed Web of Science ®Google Scholar
• LiCBiXHuangYVariants identified by hepatocellular carcinoma and chronic hepatitis B virus infection susceptibility GWAS associated with survival in HBV-related hepatocellular carcinomaPLoS One201497e10158624987808
   PubMed Web of Science ®Google Scholar
• European Association For The Study Of The Liver; European Organisation For Research And Treatment Of CancerEASL-EORTC clinical practice guidelines: management of hepatocellular carcinomaJ Hepatol201256490894322424438
   PubMed Web of Science ®Google Scholar
• AlbillosALarioMÁlvarez-MonMCirrhosis-associated immune dysfunction: distinctive features and clinical relevanceJ Hepatol20146161385139625135860
   PubMed Web of Science ®Google Scholar
• DirchwolfMRufAERole of systemic inflammation in cirrhosis: from pathogenesis to prognosisWorld J Hepatol20157161974198126261687
   PubMed Web of Science ®Google Scholar
• DirchwolfMPodhorzerAMarinoMImmune dysfunction in cirrhosis: distinct cytokines phenotypes according to cirrhosis severityCytokine201677142526517154
   PubMed Web of Science ®Google Scholar
• GardiniACScarpiEFaloppiLImmune inflammation indicators and implication for immune modulation strategies in advanced hepatocellular carcinoma patients receiving sorafenibOncotarget2016741671426714927613839
   PubMedGoogle Scholar
• Hernandez-GeaVToffaninSFriedmanSLLlovetJMRole of the microenvironment in the pathogenesis and treatment of hepatocellular carcinomaGastroenterology2013144351252723313965
   PubMed Web of Science ®Google Scholar
• TurnerNWongHLTempletonAAnalysis of local chronic inflammatory cell infiltrate combined with systemic inflammation improves prognostication in stage II colon cancer independent of standard clinicopathologic criteriaInt J Cancer2016138367167826270488
   PubMed Web of Science ®Google Scholar
• ChanSLChanAWHChanAKCSystematic evaluation of circulating inflammatory markers for hepatocellular carcinomaLiver Int201737228028927501075
   PubMed Web of Science ®Google Scholar
• MatobaKIizukaNGondoTTumour HLA-DR expression linked to early intrahepatic recurrence of hepatocellular carcinomaInt J Cancer2005115223124015688398
   PubMed Web of Science ®Google Scholar
• MathewSAbdel-HafizHRazaAFatimaKQadriIHost nucleotide polymorphism in hepatitis B virus-associated hepatocellular carcinomaWorld J Hepatol201681048549827057306
   PubMedGoogle Scholar
• OchiYHashimotoSKawabeNHLA-DQ gene polymorphisms are associated with hepatocellular carcinoma and hepatitis B surface antigen in chronic hepatitis B virus infectionHepatol Res20174775576627580643
   PubMed Web of Science ®Google Scholar
• LiYHuangQTangJCorrelation of HLA-DP/DQ polymorphisms with transplant etiologies and prognosis in liver transplant recipientsMedicine (Baltimore)20179625e720528640108
   PubMed Web of Science ®Google Scholar
• RudolphMGStanfieldRLWilsonIAHow TCRs bind MHCs, peptides, and coreceptorsAnnu Rev Immunol20062441946616551255
   PubMed Web of Science ®Google Scholar
• ManoYShirabeKYamashitaY-IPreoperative neutrophil-to-lymphocyte ratio is a predictor of survival after hepatectomy for hepatocellular carcinoma: a retrospective analysisAnn Surg2013258230130523774313
   PubMed Web of Science ®Google Scholar
• HuXMaoWParkYXuWKimBWangHBlood neutrophil-to-lymphocyte ratio predicts tumour recurrence in patients with hepatocellular carcinoma within Milan criteria after hepatectomyYonsei Med J20165751115112327401641
   PubMed Web of Science ®Google Scholar
• YangTZhuJZhaoLLymphocyte to monocyte ratio and neutrophil to lymphocyte ratio are superior inflammation-based predictors of recurrence in patients with hepatocellular carcinoma after hepatic resectionJ Surg Oncol2017115671872828127774
   PubMed Web of Science ®Google Scholar
• LiS-HWangQ-XYangZ-YPrognostic value of the neutrophil-to-lymphocyte ratio for hepatocellular carcinoma patients with portal/hepatic vein tumour thrombosisWorld J Gastroenterol20172317312228533669
   PubMed Web of Science ®Google Scholar
• TaussigMDIrene KoranMEMouliSKNeutrophil to lymphocyte ratio predicts disease progression following intra-arterial therapy of hepatocellular carcinomaHPB201719545846428190710
   PubMed Web of Science ®Google Scholar
• HungH-CLeeJ-CChengC-HImpact of neutrophil to lymphocyte ratio on survival for hepatocellular carcinoma after curative resectionJ Hepatobiliary Pancreat Sci20172455956928846835
   PubMed Web of Science ®Google Scholar
• AraiKFukumotoTKidoMPreoperative neutrophil-to-lymphocyte ratio as a predictor of survival after reductive surgery plus percutaneous isolated hepatic perfusion for hepatocellular carcinoma: a retrospective analysisSurg Today201747338539227465474
   PubMed Web of Science ®Google Scholar
• SonSHParkEYParkHHKayCSJangHSPre-radiotherapy neutrophil-to-lymphocyte ratio as an independent prognostic factor in patients with locally advanced hepatocellular carcinoma treated with radiotherapyOncotarget2017810169641697128199977
   PubMedGoogle Scholar